Force of infection of dengue serotypes in a population-based study in the northeast of Brazil

Epidemiology and Infection

Volumn 141, Issue 5, 2013, Pages 1080-1088

  Castanha, P M S ^a   Cordeiro, M T ^a,b   Martelli, C M T ^c,d   Souza, W V ^a   Marques, E T A ^a,e   Braga, C ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b Centro Integrado de Saúde Amaury de Medeiros   (Brazil)

^c FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^d FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^e UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Dengue; neutralizing antibody; prevalence

Indexed keywords

IMMUNOGLOBULIN G; NEUTRALIZING ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; BRAZIL; CHILD; CONTROLLED STUDY; DENGUE; DENGUE VIRUS 1; DENGUE VIRUS 2; DENGUE VIRUS 3; FEMALE; HELP SEEKING BEHAVIOR; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PRESCHOOL CHILD; RISK ASSESSMENT; RISK FACTOR; SELF REPORT; SUSCEPTIBLE POPULATION;

ADOLESCENT; ADULT; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; BRAZIL; CHILD; CHILD, PRESCHOOL; DENGUE; DENGUE VIRUS; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; SEROTYPING; YOUNG ADULT;

EID: 84875974801     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268812001367     Document Type: Article

References (35)

1. Guzman MG, et al. Dengue: A continuing global threat. Nature Reviews Microbiology 2010; 8: S7-16.
2. San Martin JL, et al. The epidemiology of dengue in the americas over the last three decades: A worrisome reality. American Journal of Tropical Medicine and Hygiene 2010; 82: 128-135.
3. Teixeira MG, et al. Dengue: twenty-five years since reemergence in Brazil. Cad Saude Publica 2009; 25: S7-18.
4. Swaminathan S, Batra G, Khanna N. Dengue vaccines : state of the art. Expert Opinion on Therapeutic Patents 2010; 20: 819-835.
5. Kyle JL, Harris E. Global spread and persistence of dengue. Annual Review of Microbiology 2008; 62: 71-92.
6. Rico-Hesse R. Dengue virus virulence and transmission determinants. Current Topics in Microbiology and Immunology 2010; 338: 45-55.
7. Halstead SB. Dengue. Lancet 2007; 370: 1644-1652.
8. Kuno G. Review of the factors modulating dengue transmission. Epidemiologic Reviews 1995; 17: 321-335.
9. Ferguson NM, Donnelly CA, Anderson RM. Transmission dynamics and epidemiology of dengue: insights from age-stratified sero-prevalence surveys. Philosophical Transactions of the Royal Society of London, Series B: Biological Sciences 1999; 354: 757-768.
10. Simasathien S, et al. Safety and immunogenicity of a tetravalent live-attenuated dengue vaccine in flavivirus naive children. American Journal of Tropical Medicine and Hygiene 2008; 78: 426-433.
11. Capeding RZ, et al. Live-attenuated, tetravalent dengue vaccine in children, adolescents and adults in a dengue endemic country: randomized controlled phase I trial in the Philippines. Vaccine 2011; 29: 3863-3872.
12. Reiskind MH, et al. Epidemiological and ecological characteristics of past dengue virus infection in Santa Clara, Peru. Tropical Medicine and International Health 2001; 6: 212-218.
13. Sangkawibha N, et al. Risk factors in dengue shock syndrome: A prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. American Journal of Epidemiology 1984; 120: 653-669.
14. Sanchez-Burgos GG, et al. Prevalence of neutralizing antibodies to dengue virus serotypes in university students from Tabasco, Mexico. Salud Publica de Mexico 2008; 50: 362-366.
15. Roehrig JT, Hombach J, Barrett AD. Guidelines for plaque-reduction neutralization testing of human antibodies to dengue viruses. Viral Immunology 2008; 21: 123-132.
16. Brazilian Ministry of Health (http://portal.saude. gov.br/portal/ arquivos/pdf/informe-dengue-2011-janeiro-e-marco-13-04.pdf.). Accessed 23 July 2011.
17. Braga C, et al. Seroprevalence and risk factors for dengue infection in socio-economically distinct areas of Recife, Brazil. Acta Tropica 2010; 113:234-240.
18. Instituto Brasileiro de Geografia e Estatstica (IBGE). (http://www.ibge.gov.br/cidadesat/topwindow.htm1). Accessed 23 July 2011.
19. Cordeiro MT, et al. Dengue and dengue hemorrhagic fever in the State of Pernambuco, 1995-2006. Revista da Sociedade Brasileira de Medicina Tropical 2007; 40: 605-611.
20. Montenegro D, et al. Clinical and epidemiological aspects of the dengue epidemic in Recife, PE, 2002. Revista da Sociedade Brasileira de Medicina Tropical 2006; 39: 9-13.
21. Scheaffer RL, Mendenhall W, Ott RL. Simple random sampling. In: Scheaffer RL, ed. Elementary Survey Sampling. Boston: Duxbury, 1979, pp. 48-49.
22. Morens DM, et al. Simplified plaque reduction neutralization assay for dengue viruses by semimicro methods in BHK-21 cells : comparison of the BHK suspension test with standard plaque reduction neutralization. Journal of Clinical Microbiology 1985; 22: 250-254.
23. Egger JR, et al. Reconstructing historical changes in the force of infection of dengue fever in Singapore: implications for surveillance and control. Bulletin of the World Health Organization 2008; 86: 187-196.
24. Anderson R, May R. Infectious Diseases of Humans: Dynamics and Control, 1st edn. New York: Oxford University Press, 1991, pp. 63.
25. Nogueira RM, de Araujo JM, Schatzmayr HG. Dengue viruses in Brazil, 1986-2006. Revista Panamericana de Salud Publica 2007; 22: 358-363.
26. Pessanha JEM, et al. Dengue fever in three sanitary districts in the city of Belo Horizonte, Brazil : A population-based seroepidemiological survey, 2006 to 2007. Revista Panamericana de Salud Publica 2010; 27: 252-258.
27. Siqueira JB, et al. Dengue and dengue hemorrhagic fever, Brazil, 1981-2002. Emerging Infectious Diseases 2005; 11: 48-53.
28. Chang SF, et al. Retrospective serological study on sequential dengue virus serotypes 1 to 4 epidemics in Tainan City, Taiwan, 1994 to 2000. Journal of Microbiology, Immunology and Infection 2008; 41: 377-385.
29. Wilder-Smith A, et al. Serological evidence for the cocirculation of multiple dengue virus serotypes in Singapore. Epidemiology and Infection 2005; 133: 667-671.
30. Gubler DJ. Dengue and dengue hemorrhagic fever. Clinical Microbiology Reviews 1998; 11: 480-496.
31. Cavalcanti LP, et al. Change in age pattern of persons with dengue, northeastern Brazil. Emerging Infectious Diseases 2011; 17: 132-134.
32. Endy TP, et al. Determinants of inapparent and symptomatic dengue infection in a prospective study of primary school children in Kamphaeng Phet, Thailand. PLoS Neglected Tropical Diseases 2011; 5: e975.
33. Guzman MG, et al. Epidemiologic studies on Dengue in Santiago de Cuba, 1997. American Journal of Epidemiology 2000; 152: 793-799.
34. Alencar Ximenes RA, et al. Multilevel analysis of hepatitis A infection in children and adolescents : A household survey in the Northeast and Central-west regions of Brazil. International Journal of Epidemiology 2008; 37: 852-861.
35. Rodriguez-Barraquer I, et al. From re-emergence to hyperendemicity: The natural history of the dengue epidemic in Brazil. PLoS Neglected Tropical Diseases 2011; 5: e935.